Remo Panaccione, MD

University of Calgary
Calgary, AB, Canada

Presentation(s):

• 70 - Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment: Interim Results From the LUCENT-3 Open-Label Extension Study

  Wednesday, October 25, 2023
  9:20 AM – 9:30 AM PT